WNT5A and melanoma: Moreover, we show that RNF43 could be a negative regulator of melanoma phenotype plasticity by targeting MITF-low/WNT5A-high melanoma cells (Hoek et al., 2006; Kim et al., 2017; Sensi et al., 2011; Tirosh et al., 2016).